Survival rates for patients with operable bladder cancer significantly improved by immunotherapy before and after surgery
A major clinical trial, led by the 9 1Ãâ·Ñ°æÏ of Sheffield, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to before and after surgery.